Treatment
Standard medical treatment clinical trials
We’re tracking 537 recruiting studies that include Standard medical treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07228312Recruiting
Stent treatment for unruptured brain aneurysm
This study tests a flexible stent (Choydar flow-directed mesh) to treat unruptured brain aneurysms in the neck area of the carotid or vertebral arteries. It is for people whose aneurysm has not bled and fits certain size and shape limits.
ChenzhouAges 18 years+ - NCT07179328RecruitingPhase 1
Focused ultrasound for glioblastoma during standard chemo
This trial tests whether focused ultrasound can safely open the blood-brain barrier to help your chemotherapy work better. It is for people with glioblastoma who have already completed standard surgery and chemo-radiation and are now on maintenance chemo.
Toronto, OntarioAges 18–85 - NCT07112053RecruitingPhase 2
Vaccine with hormone therapy or chemo for advanced breast cancer
This trial tests a vaccine (STEMVAC) given with your standard hormone therapy or chemotherapy. It is for people with advanced hormone receptor-positive, HER2-negative breast cancer who are already on certain treatments. The goal is to see if adding the vaccine can help control the cancer better.
Seattle, WashingtonAges 18 years+ - NCT07100730RecruitingPhase 3
A new drug for recurrent glioblastoma vs standard care
This trial tests a new targeted drug, TLX101-Tx, added to standard care for people with glioblastoma that has come back after initial treatment. It aims to see if the combination helps control the tumor better than standard care alone.
Gold Coast, QueenslandAges 18 years+ - NCT07084818Enrolling by invitation
Helping Pessary Users Manage Their Care at Home
This study tests a program to help women with pelvic organ prolapse who live in rural areas take better care of their pessary at home. You may join if you use a pessary for prolapse, have stage 2 or higher prolapse, and are not dealing with active infections or certain other conditions.
Lebanon, New HampshireAges 18 years+ - NCT07056673Recruiting
Cold plasma for moderate to severe acne
This study tests whether a treatment called 'cold atmospheric plasma' (similar to a gentle, cool gas) can improve moderate-to-severe acne. It might offer a new, drug-free option for people with many pimples or cysts.
Luoyang, HenanAges 18–40 - NCT06855134Recruiting
Genome-guided treatment for advanced rare cancers
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
AugsburgAges 18 years+ - NCT06498414RecruitingPhase 2/Phase 3
Shorter and safer treatment for latent TB
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
CotonouAges 5 years+ - NCT05539196Recruiting
Registry for Exablate treatment in Parkinson’s with medication problems
This trial is a real-world registry that follows people with Parkinson’s who are planning to get an Exablate 4000 procedure (a focused ultrasound treatment) for one-sided symptoms that are difficult to control with medication. It mainly checks outcomes and safety over time, helping doctors understand how well this treatment works in everyday care.
Baltimore, MarylandAges 30–99 - NCT04896606RecruitingPhase 1/Phase 2
Matched donor immune therapy for mild to moderate COVID-19
This early-phase study tests immune cells from a matched family donor (made to target the COVID-19 virus) to see if they can help people with mild-to-moderate COVID-19 who are hospitalized and at higher risk for getting sicker. It aims to check safety first and also look for signs of benefit.
Valhalla, New YorkAges 18–65 - NCT04383262RecruitingPhase 2
Fosamprenavir for reflux-related throat inflammation
This Phase 2 study tests whether fosamprenavir can reduce inflammation and enzyme activity in the throat area for people with laryngopharyngeal reflux (LPR). If you still have LPR symptoms despite 3 months of twice-daily reflux medicine, this trial may offer another treatment approach.
Milwaukee, WisconsinAges 18–64 - NCT04451044Enrolling by invitation
Guided heart stent planning using an inside pressure sensor
This study tests whether using a tiny pressure sensor in heart arteries during a procedure can better guide where to place a stent. It may help doctors choose the safest and most effective stent plan by more accurately measuring artery narrowing.
Birmingham, AlabamaAges 18 years+ - NCT06275958RecruitingPhase 3
Lower starting chemo dose for older adults with metastatic colorectal cancer
This study tests whether starting with a lower dose of chemotherapy works as well as the standard dose for people aged 70 and older with metastatic colorectal cancer. The goal is to find a treatment that is effective but gentler, with fewer side effects.
's-HertogenboschAges 70 years+ - NCT05405413RecruitingPhase 2
Personalized cancer treatment plan guided by tumor gene results
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
Lebanon, New HampshireAges 18 years+ - NCT06699433Recruiting
AI virtual pediatric patient training for primary care doctors
This trial uses artificial intelligence to create virtual standardized pediatric patients. It helps train doctors who work in primary care settings, like community health centers and clinics.
Guiyang, GuizhouAges Any age - NCT06293014RecruitingPhase 2
TAS-102 with bevacizumab for colorectal cancer maintenance
This trial tests a combination of two drugs, TAS-102 and bevacizumab, as a follow-up maintenance treatment for people with advanced colorectal cancer. The goal is to see if this treatment can keep the cancer from growing after initial chemotherapy and bevacizumab therapy.
Zhengzhou, HenanAges 18 years+ - NCT06327451RecruitingPhase 2
Atorvastatin plus temozolomide for EGFR-positive glioblastoma
This trial tests whether adding the cholesterol drug atorvastatin to the standard chemotherapy temozolomide improves outcomes for people with a specific type of glioblastoma (brain cancer) that is positive for the EGFR protein. It aims to find a more effective treatment for this aggressive tumor.
TianjinAges 18–60 - NCT06363825RecruitingPhase 2
New combination therapy for advanced liver cancer
This trial tests a combination of treatments for advanced liver cancer: a targeted therapy (apatinib), an immunotherapy (camrelizumab), and two local treatments (TAE and HAIC). It may be an option if you have a high tumor burden or a tumor thrombus in the portal vein and haven't had systemic treatment before.
FuzhouAges 18–80 - NCT07845929Recruiting
AI help for clearer low-dose CT images
This study tests an artificial intelligence model that helps create clearer images from a lower-dose CT scan, which could mean less radiation exposure during your procedure. It aims to improve image quality while keeping radiation doses as low as possible.
Hefei, AnhuiAges 18 years+ - NCT07698366Recruiting
Ultrasound screening for breast cancer in older women
This study tests if ultrasound screening can help find breast cancer early in women aged 65–80 who live in the community. Participants will have an ultrasound exam to check for signs of breast cancer.
Kunshan, JiangsuAges 65–80 - NCT07680140RecruitingPhase 4
Using biomarkers to choose depression treatment
This study uses a blood test (biomarker) to help pick the antidepressant that might work best for you. It compares two treatments—standard antidepressants and ketamine—in people with major depression who haven't gotten enough relief from one prior treatment.
New York, New YorkAges 18–70 - NCT07607288Enrolling by invitation
Tracking TB Treatment Results and Side Effects
This study follows patients being treated for tuberculosis with standard medications to see how well the treatment works and what side effects occur. Your medical records and check-ups help doctors understand which treatments are most effective.
Beijing, Beijing MunicipalityAges 5 years+ - NCT07272720Recruiting
Shock wave study for single kidney stones (6-15 mm)
This trial tests a new shock wave device to break apart a single kidney stone. It may be a good option if you have one stone between 6 and 15 mm that is not too hard or too far from the skin.
StockholmAges 18 years+ - NCT06859866Recruiting
Light therapy for gum disease around dental implants
This trial tests whether a special light treatment (photodynamic therapy) you can use at home can help reduce inflammation around dental implants (peri-implant mucositis). It's designed for people with early gum problems around implants, before they get worse.
RomaAges 18 years+
Common questions
- Are there clinical trials studying Standard medical treatment?
- Yes. Clin2 currently lists 537 recruiting studies that include Standard medical treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Standard medical treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Standard medical treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Standard medical treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.